Cardinal Health 414, LLC Nphs Division has been awarded a single award, firm fixed price indefinite delivery contract by the Defense Health Agency to provide radiopharmaceuticals. The contract has a potential value of $563,789.91 over its five year period of performance from October 2021 through September 2026.
Under the contract, Cardinal Health will supply radiopharmaceutical products to support nuclear medicine procedures at military treatment facilities. Task orders will be issued against the contract on an as-needed basis through September 2030. Performance will take place at Cardinal Health's location in Jacksonville, Florida, utilizing its existing infrastructure to fulfill delivery orders without the use of major subcontractors.
As the agency tasked with healthcare support for military members, the Defense Health Agency leverages strategic sourcing contracts to efficiently obtain necessary medical supplies. This contract aims to procure radiopharmaceuticals that are utilized in nuclear imaging scans to diagnose and treat conditions for the Department of Defense beneficiary population. Cardinal Health's award was made without any set-aside designations, and the company will deliver the specified pharmaceuticals over the five year base period to meet the Defense Health Agency's requirements.
Generated 1/5/24, 10:16 PM